← Insider Monitor
ACHIEVE LIFE SCIENCES, INC. logo
ACHV

ACHIEVE LIFE SCIENCES, INC.

Nasdaq · In Vitro & In Vivo Diagnostic Substances

1
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Achieve Life Sciences is a clinical-stage pharmaceutical company developing cytisinicline, a smoking and vaping cessation treatment, and is advancing it through late-stage clinical trials toward regulatory approval.

Industry
In Vitro & In Vivo Diagnostic Substances
Headquarters
Seattle, WA
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Stewart Richard AlistairInsiderSell$175KAug 19, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for ACHV.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable ACHV activity by email

Free alerts for the insider and congressional trades worth watching.

SMS is optional: we only save your number if you check the consent box and provide a valid number. US mobile numbers only.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.